Literature DB >> 27881387

Intrauterine growth restriction influences vascular remodeling and stiffening in the weanling rat more than sex or diet.

R Blair Dodson1,2,3,4, Thomas A Miller5, Kyle Powers1,3,4, Yueqin Yang5, Baifeng Yu6, Kurt H Albertine6, Erin K Zinkhan7.   

Abstract

Intrauterine growth restriction (IUGR) increases the incidence of adult cardiovascular disease (CVD). The sex-specific developmental mechanisms for IUGR-induced and Western high-fat diet (HFD) modification of CVD remain poorly understood. We hypothesized a maternal HFD in the Sprague-Dawley rat would augment IUGR-induced CVD in the offspring through decreased cardiac function and increased extracellular matrix (ECM) remodeling and stiffness in a sex-specific manner. HFD or regular diet (Reg) was given from 5 wk before mating through postnatal day (PND) 21. IUGR was induced by uterine artery ligation at embryonic day 19.5 (term = 21.5 days). At PND 21, echocardiographic assessments were made and carotid arteries tested for vascular compliance using pressure myography. Arterial samples were quantified for ECM constituents or fixed for histologic evaluation. The insult of IUGR (IUGR + Reg and IUGR + HFD) led to increased mechanical stiffness in both sexes (P < 0.05). The combination of IUGR + HFD increased diastolic blood pressure 47% in males (M) and 35% in females (F) compared with the Con + Reg (P < 0.05). ECM remodeling in IUGR + HFD caused fewer (M = -29%, F = -24%) but thicker elastin bands (M = 18%, F = 18%) and increased total collagen (M = 49%, F = 34%) compared with Con + Reg arteries. Remodeling in IUGR + HFD males increased medial collagen and soluble collagen (P < 0.05). Remodeling in IUGR + HFD females increased adventitial collagen and wall thickness (P < 0.05) and decreased matrix metalloproteinase 2 (MMP-2), advanced glycosylation end products (AGE), and receptor AGE (RAGE; P < 0.05). In summary, both IUGR + Reg and IUGR + HFD remodel ECM in PND 21 rats. While IUGR + HFD increases blood pressure, IUGR but not HFD increases vascular stiffness suggesting a specific mechanism of vascular remodeling that can be targeted to limit future disease. NEW &amp; NOTEWORTHY: We report intrauterine growth restriction (IUGR) increases vascular stiffening in both male and female rats through increased collagen content and altered elastin structure more than a high-fat diet (HFD) alone. Our study shows the importance of stiffness supporting the hypothesis that there are physiologic differences and potential windows for early intervention targeting vascular remodeling mechanisms.
Copyright © 2017 the American Physiological Society.

Entities:  

Keywords:  collagen; elastin; extracellular matrix; high-fat diet

Mesh:

Substances:

Year:  2016        PMID: 27881387     DOI: 10.1152/ajpheart.00610.2016

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  10 in total

1.  Maternal nutrient restriction during pregnancy and lactation leads to impaired right ventricular function in young adult baboons.

Authors:  Anderson H Kuo; Cun Li; Hillary F Huber; Matthias Schwab; Peter W Nathanielsz; Geoffrey D Clarke
Journal:  J Physiol       Date:  2017-05-18       Impact factor: 5.182

2.  Statistical considerations in reporting cardiovascular research.

Authors:  Merry L Lindsey; Gillian A Gray; Susan K Wood; Douglas Curran-Everett
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-07-20       Impact factor: 4.733

3.  Role of fetal nutrient restriction and postnatal catch-up growth on structural and mechanical alterations of rat aorta.

Authors:  Perla Y Gutiérrez-Arzapalo; Pilar Rodríguez-Rodríguez; David Ramiro-Cortijo; Ángel L López de Pablo; María Rosario López-Giménez; Luis Condezo-Hoyos; Stephen E Greenwald; Maria Del Carmen González; Silvia M Arribas
Journal:  J Physiol       Date:  2018-01-31       Impact factor: 5.182

4.  Altered Placental Chorionic Arterial Biomechanical Properties During Intrauterine Growth Restriction.

Authors:  Shier Nee Saw; Jess Jia Hwee Tay; Yu Wei Poh; Liying Yang; Wei Ching Tan; Lay Kok Tan; Alys Clark; Arijit Biswas; Citra Nurfarah Zaini Mattar; Choon Hwai Yap
Journal:  Sci Rep       Date:  2018-11-08       Impact factor: 4.379

5.  Guidelines for authors and reviewers on antibody use in physiology studies.

Authors:  Heddwen L Brooks; Merry L Lindsey
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-01-05       Impact factor: 4.733

6.  The Placental Transcriptome in Late Gestational Hypoxia Resulting in Murine Intrauterine Growth Restriction Parallels Increased Risk of Adult Cardiometabolic Disease.

Authors:  Alison Chu; David Casero; Shanthie Thamotharan; Madhuri Wadehra; Amy Cosi; Sherin U Devaskar
Journal:  Sci Rep       Date:  2019-02-04       Impact factor: 4.379

7.  Postnatal Growth Restriction in Mice Alters Cardiac Protein Composition and Leads to Functional Impairment in Adulthood.

Authors:  Joseph R Visker; Lawrence J Dangott; Eric C Leszczynski; David P Ferguson
Journal:  Int J Mol Sci       Date:  2020-12-12       Impact factor: 5.923

8.  Associations between height and blood pressure in the United States population.

Authors:  Brianna Bourgeois; Krista Watts; Diana M Thomas; Owen Carmichael; Frank B Hu; Moonseong Heo; John E Hall; Steven B Heymsfield
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

9.  Intrauterine exposure to chronic hypoxia in the rat leads to progressive diastolic function and increased aortic stiffness from early postnatal developmental stages.

Authors:  Praveen Kumar; Jude S Morton; Amin Shah; Victor Do; Consolato Sergi; Jesus Serrano-Lomelin; Sandra T Davidge; Donna Beker; Jody Levasseur; Lisa K Hornberger
Journal:  Physiol Rep       Date:  2020-01

10.  Maternal Predictors of Disparate Outcomes in Children With Single Ventricle Congenital Heart Disease.

Authors:  Priyanka Asrani; Nelangi M Pinto; Michael D Puchalski; Zhining Ou; Robert M Silver; Erin K Zinkhan; Cara C Heuser; Amy Nance; Thomas A Miller
Journal:  J Am Heart Assoc       Date:  2020-06-09       Impact factor: 5.501

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.